NCT01909232

A Clinical Trial for the Treatment of Depression With Repetitive Transcranial Magnetic Stimulation (rTMS)

A Prospective, Double-Blind, Randomized, Parallel-Group, Sham-Controlled Feasibility Trial of Multi-Coil Repetitive Transcranial Magnetic Stimulation (rTMS) for the Treatment of Major Depressive Disorder

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 92 (actual)
• Sponsor: Cervel Neurotech, Inc. · Industry
• Sex: All
• Age: 18 Years – 70 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to determine whether the Cervel Neurotech rTMS device is safe and effective in the treatment of depression in people who do not get better with antidepressant medications or cannot take antidepressant medications.

Conditions

• Depressive Disorder, Major

Interventions

Type	Name	Description
DEVICE	Active Cervel Neurotech Multi-Coil Transcranial Magnetic Stimulator	The Cervel Neurotech multi-coil transcranial magnetic stimulator is an investigational repetitive transcranial stimulation (rTMS) device. In the active group, magnetic power output will be delivered to the subject through the coils.
DEVICE	Inactive Cervel Neurotech Multi-Coil Transcranial Magnetic Stimulator	The Cervel Neurotech multi-coil transcranial magnetic stimulator is an investigational repetitive transcranial stimulation (rTMS) device. In the inactive group, no magnetic power output will be delivered to the subject through the coils.

Timeline

• Start date: 2013-07-01
• Primary completion: 2014-06-01
• Completion: 2014-07-01
• First posted: 2013-07-26
• Last updated: 2016-07-28

Locations

6 sites across 1 country: United States